Answers are grounded in this paper and cite their sources.
Objective: To assess the antibacterial and antifungal activity in vitro of a patented Spirulina extract on sensitive and multidrug-resistant bacteria, yeasts, and filamentous fungi commonly causing skin infections. Methods: The antimicrobial activity was tested using the drop dilution assay on the Gram-positive bacteria Staphylococcus aureus (wildtype), a methicillin resistant S. aureus, S. epidermidis, S. haemolyticus, Streptococcus pyogenes, the Gram-negative multidrug resistant Pseudomonas aeruginosa, the yeasts Candida albicans and C. tropicalis, and the dermatophytes Trichophyton rubrum and Microsporum gypseum. Results: A concentration of 4 g of Spirulina extract per 100 mL of Mueller Hinton agar completely inhibited the growth of all tested bacteria and yeasts, and suppressed dermatophytes growth by 5 log 10 units. Conclusion: The Spirulina extract tested could be used as an effective natural, broad-spectrum antimicrobial agent, with potential applications in the therapy of bacterial and fungal infectious diseases.
No takes yet. Share an insight, caveat, or question.
Pianta et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: